Medical treatment of hyperadrenocorticism in the dog.
Braddock
J A
JA
Faculty of Veterinary Science, The University of Sydney, New South Wales, 2006. jody@mail.usyd.edu.au
D000308:Adrenocortical Hyperfunction / Q000188:drug therapy / Q000662:veterinary*; D000616:Aminoglutethimide / Q000627:therapeutic use; D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D013196:Dihydrotestosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005045:Etomidate / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D008797:Metyrapone / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D012642:Selegiline / Q000627:therapeutic use
D013196:Dihydrotestosterone; D000616:Aminoglutethimide; D012642:Selegiline; D003533:Cyproheptadine; D001971:Bromocriptine; D008939:Mitotane; C009954:trilostane; D007654:Ketoconazole; D005045:Etomidate; D008797:Metyrapone